Search for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

prescription and over-the-counter medicines and medical devices;

beauty products and cosmetics, natural remedies and other pharmaceutical products

Stamibio Beauty - Dermocosmetic Anti-aging cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, BIO-PLEX RNA, OLIGOELEMENTI, JOJOBA OIL, RHODIOLA ROSEA, GINSENG, GUARANÀ, OENOTHERA BIENNIS, Coenzyme Q10 (Ubiquinone)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Lotion Dermocosmetic Restructuring Lotion

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GINGKO BILOBA, SALVIA OFFICINALIS, VITAMIN E
Other information: Lotion

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Calmderm Fluid dermocosmetic cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GLYCYRRHETINIC ACID , VITAMIN E , PROVITAMIN D , BOSWELLIA SERRATA, LECITHIN, ZANTHALENE, CALMING AGENT (SYMSITIVE)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Derm Skin-protecting dermocosmetic cream

Marketed by: GUNA
Active ingredient: Roe extract, Glycyrrhetinic acid, Vitamin E (Tocopheryl acetate), 7-Dehydrocholesterol ,Boswellia serrata, Zanthoxylum alatum
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Serum Dermocosmetic serum

Marketed by: GUNA
Active ingredient: ROE EXTRACT, HIGH MOLECULAR WEIGHT HYALURONIC ACID, INOSITOL, HOP EXTRACT, COCOA EXTRACT, GINSENG, GUARANÀ,LOTUS EXTRACT, HYDROLYZED DNA AND RNA, MACA EXTRACT, TRACE ELEMENTS, ANTI-SPOT COMPLEX
Other information: Serum

Available in: Italy
Language: English
Source: myHealthbox

Fluimucil 200 mg granules for oral solution

Marketed by: Zambon S.p.A.
Active ingredient: Acetylcysteine
Other information: Granules for oral solution - 200mg

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

Concerta XL 27 mg prolonged-release tablets

Marketed by: Imbat Limited
Active ingredient: Methylphenidate hydrochloride
Other information: Tablets - 27 mg

Available in: Ireland
Language: English
Source: myHealthbox

Concerta XL 36 mg prolonged-release tablets

Marketed by: Imbat Limited
Active ingredient: Methylphenidate hydrochloride
Other information: Tablets - 36 mg

Available in: Ireland
Language: English
Source: myHealthbox

Rasilez 150 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren
Other information: Film-coated tablet - 150 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/25 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 25 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 300 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 300 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Eliquis 2.5 mg film-coated tablets

Marketed by: Bristol-Myers Squibb, Pfizer EEIG
Active ingredient: Apixaban
Other information: Film-coated tablet - 2.5 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 300 units/ml solution for injection in a pre-filled pen

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 300 units insulin glargine (equivalent to 10.91 mg). Each pen contains 1.5 ml of solution for injection, equiva

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a vial

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine* (equivalent to 3.64 mg). Each vial contains 5 ml of solution for injection, equival

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge for OptiClik

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product...

Europe - EMA - European Medicines Agency

4-7-2015

Scientific Opinion on the safety of UV-treated bread as a novel food EFSA Panel on Dietetic Products, Nutrition and Allergies

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel) was asked to carry out the additional assessment for UV-treated br...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific Opinion on the substantiation of a health claim related to Symbiosal® and lowering of blood pressure and reduced risk of hypertension pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following an application from Han-Asiabiotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific and technical assistance on the evaluation of the temperature to be applied to pre-packed fishery products at retail level

European Food Safety Authority Relevant hazards associated with pre-packed fresh fishery products were identified through a literature search. The main temperature-dependent hazards identified are histamine formation, Listeria monocytogenes, Clostridium...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Updating risk management recommendations to limit exposure of non-target Lepidoptera of conservation concern in protected habitats to Bt-maize pollen

EFSA Panel on Genetically Modified Organisms (GMO) Using mathematical modelling, the EFSA GMO Panel has previously quantified the risk to non-target (NT) Lepidoptera of conservation concern, potentially occurring within protected habitats, associated w...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific Opinion on the re-evaluation of oxidised polyethylene wax (E 914) as a food additive

EFSA Panel on Food Additives and Nutrient Sources added to food (ANS) The EFSA ANS Panel delivered a scientific opinion re-evaluating the safety of oxidised polyethylene wax (OPEW) (E 914) as a food additive. E 914 is authorised at quan...

Europe - EFSA - European Food Safety Authority EFSA Journal

2-7-2015

LOSORTAN POTASSIUM (Losartan Potassium) Tablet, Film Coated [Cardinal Health]

Updated Date: Jul 2, 2015 EST...

US - DailyMed

2-7-2015

NITROUS OXIDE Gas [AIR SUPPLY OF NORTH TEXAS]

Updated Date: Jul 2, 2015 EST...

US - DailyMed

2-7-2015

CLOPIDOGREL (Clopidogrel Bisulfate) Tablet, Film Coated [Cardinal Health]

Updated Date: Jul 2, 2015 EST...

US - DailyMed

2-7-2015

PURIFYING OXYGENATING SERUM (Glycerin, Dimethicone) Cream [Casmara Cosmetics, SA]

Updated Date: Jul 2, 2015 EST...

US - DailyMed

2-7-2015

OPIUM (Raw Opium Gum) Pellet [Remedy Makers]

Updated Date: Jul 2, 2015 EST...

US - DailyMed

2-7-2015

BICARUVAS (Antacid) Powder, For Solution [PROSANA DISTRIBUCIONES, S.A. DE C.V.]

Updated Date: Jul 2, 2015 EST...

US - DailyMed